SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Palatin (PLTN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TradeOfTheDay who wrote ()10/15/1997 7:48:00 PM
From: TradeOfTheDay   of 61
 
techstocks.com


" Michael Weiss is a Director of Palatin
Technologies and Interim Chairman of Procept's Board. He has been a Palatin
Director for a year as a result of a merger on June 25, 1996, which resulted in a
change of controlling interest within Palatin. Within the last year the stock price went
from approx. forty cents to a little less than $2.00. Today, there is 12,081,496
common stock (one vote per share) and 137,780 preferred stock (approx. 80.6 votes
per share). "
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext